US › Healthcare

Aquestive Therapeutics Inc (AQST)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$3.74-1.32%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$14.4M
Revenue YoY
+65.7%
Net profit
$-8.1M
Profit YoY
+64.9%
EPS
$-0.05
EPS estimate
$-0.13
Net margin
-55.8%

EPS came in at -0.05 against a street estimate of -0.13 — a beat of 61.5%.

Key statistics

Market cap
$463.6M
Forward P/E
0.0
P/B
14.15
Book value
$-0.27
EPS (TTM)
$-0.61
52-week high
$7.55
52-week low
$2.93
50-day MA
$4.12
200-day MA
$4.70
Beta
1.45

Analyst view

Analysts rate Aquestive Therapeutics Inc a strong buy (9 buy, 0 hold, 0 sell out of 9) with an average price target of $8.89.

Shareholding

Insiders
3.06%
Institutions
58.77%

Largest institutional holders

FundStake
Bratton Capital Management, L.P.7.82%
BlackRock Inc5.98%
RTW INVESTMENTS, LLC5.92%
Vanguard Capital Management, LLC3.54%
Federated Hermes Inc2.34%
Balyasny Asset Management LLC2.31%
State Street Corp2.03%
Samsara BioCapital, LLC1.99%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Aquestive Therapeutics Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.